PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients

This study evaluates promoter methylation of the programmed cell death ligand 1 (PD-L1) as a biomarker in a cohort of 383 colorectal cancer patients. PD-L1 methylation (mPD-L1) was inversely correlated with PD-L1 mRNA expression (p = 0.001) and was associated with significantly shorter overall survi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncoimmunology
Main Authors: Goltz, Diane, Gevensleben, Heidrun, Dietrich, Jörn, Dietrich, Dimo
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2016
Teme:
Brief Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5283627/
https://ncbi.nlm.nih.gov/pubmed/28197377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1257454
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki